Position in LLY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$9,679,400
+$3,102,125 QoQ
Shares Held
8,070
+12.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#1,276
of 4,605 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Roundview Capital LLC holds $44,317,424 across 9 Drug Manufacturers - General names. LLY ranks #2 (21.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
72,050 | $18,298,538 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
8,070 | $9,679,400 | |
| 3 | ABBV |
AbbVie Inc.
|
30,467 | $7,666,715 | |
| 4 | MRK |
Merck & Co., Inc.
|
42,411 | $5,449,813 | |
| 5 | NVO |
Novo Nordisk A S
|
32,028 | $1,535,422 | |
| 6 | PFE |
Pfizer Inc
|
23,438 | $564,387 | |
| 7 | NVS |
Novartis AG
|
2,707 | $424,241 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,618 | $381,329 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,679,400 | 8,070 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $6,577,275 | 7,151 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $7,736,622 | 7,199 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $4,779,432 | 6,264 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,404,344 | 5,650 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $3,895,817 | 4,717 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $3,402,976 | 4,408 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,052,063 | 3,445 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,036,644 | 3,354 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,466,133 | 3,170 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,651,412 | 2,833 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,250,438 | 2,328 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,072,557 | 2,287 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $812,875 | 2,367 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,011,181 | 2,764 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $841,033 | 2,601 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $737,299 | 2,274 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $588,776 | 2,056 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $553,268 | 2,003 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $462,793 | 2,003 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $367,920 | 1,603 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $299,472 | 1,603 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $219,998 | 1,303 | Shares | Sole | 2021-02-08 | |
| 2020-06-30 | $211,299 | 1,287 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||